glycyrrhizic acid has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, YZ; Lv, XL; Tang, Y; Wang, JR | 1 |
| Faizah, O; Farihah, HS; Nazrun, SA; Nirwana, SI; Norazlina, M; Norliza, M; Suhana, MR | 1 |
2 other study(ies) available for glycyrrhizic acid and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Glycyrrhizin improves bone metabolism in ovariectomized mice via inactivating NF-κB signaling.
Topics: Animals; Bone Density Conservation Agents; Bone Resorption; Disease Models, Animal; Female; Glycyrrhizic Acid; Humans; Mice; Mice, Inbred C57BL; Monocytes; NF-kappa B; Osteoclasts; Osteogenesis; Osteoporosis, Postmenopausal; Ovariectomy; RAW 264.7 Cells; Signal Transduction | 2021 |
Piper sarmentosum prevents glucocorticoid-induced osteoporotic bone resorption by increasing 11β-hydroxysteroid dehydrogenase type 1 activity.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adrenalectomy; Animals; Biomarkers; Bone Resorption; Corticosterone; Dexamethasone; Drug Evaluation, Preclinical; Enzyme Induction; Femur; Glucocorticoids; Glycyrrhizic Acid; Male; Osteoblasts; Osteoclasts; Osteoporosis; Phytotherapy; Piper; Plant Extracts; Rats; Rats, Sprague-Dawley | 2011 |